吲哚胺2,3-双加氧酶
子痫前期
下调和上调
间质细胞
胎盘
免疫组织化学
胎儿
滋养层
内科学
生物
医学
内分泌学
男科
免疫学
怀孕
色氨酸
氨基酸
基因
生物化学
遗传学
作者
Naoyuki Iwahashi,Madoka Yamamoto,Sakiko Nanjo,Saori Toujima,Sawako Minami,Kazuhiko Ino
标识
DOI:10.1016/j.jri.2017.01.003
摘要
Previous studies have shown that indoleamine 2, 3-dioxygenase (IDO), an immunosuppressive enzyme that converts tryptophan to kynurenine, is expressed in the placenta and might play a role in the maintenance of pregnancy, although its associations with the pathogeneses of preeclampsia (PE) and fetal growth restriction (FGR) remain unclear. The objective of this study was to investigate the differences in IDO expression among normal, PE, and FGR placentas, and the associations between IDO expression and clinical symptoms, or the expression of fms-like tyrosine kinase receptor-1 (Flt-1). Immunohistochemical studies of IDO and Flt-1 expression were performed in human placentas that were complicated with FGR alone (n = 19), PE alone (n = 20), or both PE and FGR (n = 39), and gestational age-matched controls (n = 23). It was found that IDO was expressed on endothelial cells in the villous stroma, while Flt-1 was located on trophoblast cells. The IDO expression level of the PE alone group was significantly lower than those of the FGR alone and control groups. The IDO expression of the PE + FGR group was significantly lower than that of the FGR alone group. Lower IDO expression was significantly correlated with more severe maternal hypertension or proteinuria in PE patients, who exhibited higher Flt-1 expression. The late onset PE patients exhibited significantly lower IDO expression than the early onset PE patients. This study demonstrated that the downregulation of IDO expression on the endothelial cells of the villous stroma was associated with PE, but not FGR, suggesting that IDO might be involved in the pathophysiology of PE.
科研通智能强力驱动
Strongly Powered by AbleSci AI